Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 02/04/2011 14034_de.jpg

    Nanosensor detects pathogens

    Researchers from the Stuttgart-based Max Planck Institute of Solid State Research have succeeded in detecting tiny traces of DNA using sensors made from carbon nanotubes. The sensors are highly selective for specific DNA sequences and it is envisaged that they will be used for the rapid examination of blood samples.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanosensor-detects-pathogens
  • Press release - 10/03/2011 13882_de.jpg

    Novel High-Resolution Methods in Fluorescence Microscopy

    Heidelberg scientists have developed a new method by which the physical limits in high-resolution light microscopy can be overcome with the aid of chemical reactions. The scientists replaced light-dependent processes by chemical reactions for light-independent switching of fluorescent probes to mark cellular structures for high-resolution optical microscopy. This method opens up new application vistas for fluorescence microscopy.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-high-resolution-methods-in-fluorescence-microscopy
  • Article - 07/03/2011 Prof. Dr. Thomas Brunner

    Thomas Brunner: steroid synthesis in the intestine

    A research team led by Prof. Dr. Thomas Brunner at the University of Konstanz has found out that intestinal epithelial cells are able to synthesise anti-inflammatory steroids glucocorticoids following immunological stress which makes a considerable contribution to the maintenance of local immune homoeostasis. Brunner plans to use his findings to develop a therapeutic approach for the treatment of inflammatory bowel diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/news/thomas-brunner-steroid-synthesis-in-the-intestine
  • Article - 06/03/2011 13837_de.jpg

    Heidelberg Translational Lung Research Centre

    University and non-university research institutions in Heidelberg that carry out research into lung diseases have established an expert network – the Heidelberg Translational Lung Research Centre – which is part of the new BMBF-funded German Centre for Lung Research. In Heidelberg, research focuses on the development and treatment of cystic fibrosis, chronic obstructive pulmonary diseases and lung cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/heidelberg-translational-lung-research-centre
  • Press release - 02/03/2011 Immatics Logo

    immatics appoints Dr. Harald Stock to its Board

    immatics biotechnologies GmbH, a late-stage biopharmaceutical company developing therapeutic vaccines that are active against cancer, today announced the appointment of Dr. Harald F. Stock to the board of directors, effective February 2011.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/immatics-appoints-dr-harald-stock-to-its-board
  • Press release - 28/02/2011 09096_de.jpg

    Heidelberg "start-up" wins the German Industry’s Innovation Award 2010

    PEPperPRINT GmbH has won the 2010 German Industry’s Innovation Award in the category “Start-Up Companies”. The Heidelberg-based biotechnology company was awarded the prize by the German Minister of Education and Research, Dr. Annette Schavan, at a German industry festive event recently held in the Frankfurt Congress Centre.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-start-up-wins-the-german-industry-s-innovation-award-2010
  • Article - 26/02/2011 13797_de.jpg

    Researchers from Ulm identify congenital genetic defect

    Researchers led by the Ulm paediatrician Holger Cario have identified a rare, congenital genetic defect that leads to the dysregulation of the folic acid metabolism, resulting in aenemia, epilepsy and learning difficulties in children. All aspects of the disease can be treated quite successfully with the exception of the cramps associated with the defect.

    https://www.gesundheitsindustrie-bw.de/en/article/news/researchers-from-ulm-identify-congenital-genetic-defect
  • Dossier - 07/02/2011 Picture shows a target, symbolising the vision of personalised medicine

    The era of personalised medicine is dawning

    A promising future does not easily disappear into thin air. This is certainly the case with the vision of personalised medicine. For many years, biomedical researchers have vaunted the potential benefits of their findings despite the fact that neutral observers do not think that personalised medicine will really take off within the next 15 or 20 years. Moreover personalised medicine is a controversial term. So what is the state of play right now?

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/the-era-of-personalised-medicine-is-dawning
  • Article - 07/02/2011 13564_de.jpg

    The discovery of the individual as business model

    The move towards personalised medicine has made considerable progress, in particular in the field of oncology, where it is leading to the close integration of diagnostics and therapy as well as to the development of profitable new business models, some of which have controversial exclusive legal claims.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-discovery-of-the-individual-as-business-model
  • Press release - 26/01/2011

    Uncovering the Genetics of Prostate Cancer

    Germany will contribute another project to the International Cancer Genome Consortium ICGC. Coordinated by the German Cancer Research Center and the University Medical Center Hamburg-Eppendorf physicians and molecular biologists will now start to investigate the genetic causes of early prostate cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/uncovering-the-genetics-of-prostate-cancer-1
  • Press release - 19/01/2011

    Colonoscopy Provides Protection from Cancer on Both Sides of the Colon

    Scientists of the German Cancer Research Center DKFZ in Heidelberg have now shown that inspection of both sides of the colon also reduces cancer risk in the right part of the colon by more than 50 percent. The overall risk was found to be 77 percent lower. This means that colonoscopy provides very good protection from colon cancer - even though it is not a 100 percent guarantee.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/colonoscopy-provides-protection-from-cancer-on-both-sides-of-the-colon
  • Article - 29/11/2010 12950_de.jpg

    CYP2D6 and the oestrogen receptor

    The medicinal adjuvant therapy of breast cancer is a good example of how important it is being aware that different patients metabolise drugs differently. This knowledge plays a key role in the prescription of effective drugs at the correct dose and in preventing adverse reactions and interactions with concomitant drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cyp2d6-and-the-oestrogen-receptor
  • Press release - 25/11/2010

    BD Diagnostics and Lonza Collaborate

    BD Diagnostics, a segment of BD (Becton, Dickinson and Company), and Lonza Group Ltd announced today that they have entered into an exclusive licensing and collaboration agreement for Lonza to commercialize its microCompass™ molecular assays on the BD MAX™ System.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/bd-diagnostics-and-lonza-collaborate
  • Press release - 16/11/2010 11459_de.jpg

    Summit conference on regional development in the Rhine-Neckar Metropolitan Region

    To learn from leading regional developers this was the goal set by the representatives of the Biotechnology Cluster Rhine-Neckar BioRN for the Regional Development Summit. Representatives from business science and politics in the Rhine-Neckar Metropolitan Region met in the Villa Bosch in Heidelberg on November 11 with experts from the leading international high-tech sites in Leuven Belgium Cambridge UK and Israel.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/summit-conference-on-regional-development-in-the-rhine-neckar-metropolitan-region
  • Press release - 15/11/2010 12969_de.png

    ASPEX- an advanced Schizosaccharomyces expression system

    The ASPEX system Asahi Glass Schizosaccharomyces Expression is a full-scale contract manufacturing service for recombinant proteins with up to the 3000 L scale. It is based on S. pombe an endotoxin-free fission yeast isolated from east African beer. Examples for gene expressions in the ASPEX system are manifold. The dedicated production facility located close to the Research Center is organized under cGMP rules and thus enables supply of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/aspex-an-advanced-schizosaccharomyces-expression-system
  • Article - 13/11/2010 12780_de.jpg

    Franz Porzsolt is turning existing beliefs and dogmas on their head

    Porzsolt a 64-year-old clinical economist specialist in internal medicine and oncologist enjoys turning accepted truths on their head. Many colleagues regard him as an outspoken critic of others for his tendency to refer to science as theory and clinical settings as practice. Porzsolt criticises evidence-based medicine as it is currently understood and applied.

    https://www.gesundheitsindustrie-bw.de/en/article/news/franz-porzsolt-is-turning-existing-beliefs-and-dogmas-on-their-head
  • Article - 05/11/2010 12821_de.jpg

    DITABIS: Custom-made analysis systems for research and industry

    Outstanding quality, clever product design, flexibility and rapid implementation make Pforzheim-based DITABIS Digital Biomedical Imaging Systems AG a true racing stable for device developments. The company’s key competences include imaging plate technology and fluorescence scanning, procedures that can be used to record high-resolution digital images in a contrast-rich and highly linear way. The innovative imaging systems are predominantly used…

    https://www.gesundheitsindustrie-bw.de/en/article/news/ditabis-custom-made-analysis-systems-for-research-and-industry
  • Press release - 04/11/2010

    LifeCodexx Appoints Head of Commercial Operations

    Dr. Martin Burow, a proven expert in the field of prenatal diagnostics, has joined the LifeCodexx team as Head of Commercial Operations.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/lifecodexx-appoints-head-of-commercial-operations
  • Article - 25/10/2010 Photo of Dr. Anglika Rück, head of the mircoscopy team at Ulm-based ILM.<br />

    Angelika Rück visualises the dance of molecules

    Angelika Rück measures the luminescence time of molecules in order to find out whether proteins are speaking with each other. She hopes that she will soon be able to differentiate inflammation from tumours. Rück who is head of microscopy at the Ulm-based ILM has worked hard with her colleagues to make the Eselsberg-based Ulm University location one of southern Germanys leading life cell imaging centres.

    https://www.gesundheitsindustrie-bw.de/en/article/news/angelika-rueck-visualises-the-dance-of-molecules
  • Article - 18/10/2010 12743_de.jpg

    DNA analysis is becoming more automated

    GATC Biotech AG is already on the lookout for next generation sequencing technologies in the form of real-time single-molecule sequencing. In an interview with BIOPRO Thomas Pohl CTO of GATC Biotech AG explains why the company is continuously expanding its existing equipment with the latest global technologies.

    https://www.gesundheitsindustrie-bw.de/en/article/news/dna-analysis-is-becoming-more-automated
  • Dossier - 18/10/2010 The photo shows a sequencing laboratory at GATC whose employees operate big sequencing systems.<br />

    New machines for the life sciences

    Hardware and software applications have become an integral part of the everyday life of life sciences researchers, developers and service providers. It is impossible to imagine life science applications without effective hardware and software applications – from computer-assisted drug screening to the automatic production of biosensors for rapid, mobile, purse-size bacterial test devices. Trends such as automation and miniaturisation lead to ever…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/new-machines-for-the-life-sciences
  • Press release - 13/10/2010 12629_de.jpg

    GATC Biotech to be First European Service Provider for the PacBio RS

    GATC Biotech announced today that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRT™) sequencing technology. The new PacBio RS will be the fifth sequencing technology for GATC Biotech. The system is planned for installation in early 2011.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-to-be-first-european-service-provider-for-the-pacbio-rs
  • Article - 04/10/2010 Dr. Kerstin Stemmer and a colleague from the University of Konstanz analysing results

    Dr. Kerstin Stemmer: important approaches for the early identification of carcinogenic substances

    Dr. Kerstin Stemmer from the University of Konstanz has found a way to identify the carcinogenic potential of substances in just a few days using state-of-the-art technology and new investigation methods. This is the first time that researchers have been able to reduce the time and the number of animals used in carcinogenesis studies.

    https://www.gesundheitsindustrie-bw.de/en/article/news/dr-kerstin-stemmer-important-approaches-for-the-early-identification-of-carcinogenic-substances
  • Press release - 21/09/2010 12119_de.jpg

    The National Cohort study

    The objective of the National Cohort study, the largest prospective study ever conducted in Germany, is to provide answers to a broad range of epidemiological questions, to identify risk factors for common diseases and to open up new treatment pathways. This project is being planned since beginning 2009 by the health centers of the Helmholtz Association in a network with partners from universities and other public research institutions.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-national-cohort-study
  • Dossier - 20/09/2010 Micrograph of a nerve cell of a Alzheimer's patient. The toxic beta-amyloid aggregations, which are responsible for the disease, are stained brown.

    Neurodegenerative diseases

    It is estimated that around 1.2 million people in Germany suffer from dementia, and around 200,000 people are diagnosed with neurodegenerative diseases every year. It is expected that by 2050, one in three people in Germany will be over 60 and the number of age-related diseases, particularly dementias, for which no effective curative therapy is currently available, will increase considerably. Given the large numbers of elderly people and…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/neurodegenerative-diseases

Page 12 / 18

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 18
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search